Peptide-Decorated Ultrasmall Superparamagnetic Nanoparticles as Active Targeting MRI Contrast Agents for Ovarian Tumors
- 16 October 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 11 (44) , 41038-41050
Abstract
Magnetic resonance imaging (MRI) is widely applied in medical research and diagnosis, and MRI contrast medium plays a crucial role in improving the sensitivity of detection. Ultrasmall superparamagnetic iron oxides (USPIOs) exhibit the potential as a T2 enhancement contrast medium for MRI due to their excellent magnetic response performance, however, to endow it with specific tumor targetability while ensuring low cytotoxicity and long-term circulation performance has always been a hot topic in this field. In this study, a well-designed procedure of chemical coprecipitation, surface modification and peptide grafting was applied to synthesize the active tumor targeting [email protected], in which Pluronic F127 (F127) and the peptide WSGPGVWGASVK (peptide-WSG) were selected as the template agent and the ovarian tumor targeting ligand respectively. The results showed that single [email protected] particles were Fe3O4 nanoparticles regulated by confinement effect of F127 micelles with uniform globular morphology and size (~9 nm), and peptide-WSG was grafted for tumor targetability. They presented superparamagnetic behavior with high T2 relaxivity (r2 = 278.15 mM−1s−1), and in vitro targetability for SKOV-3 cells due to the special binding between peptide-WSG and specific receptors of SKOV-3. The test results in vivo verified the targetability of [email protected] by their specific aggregation in the tumor regions, leading to the T2-weighted MRI contrast enhancement. Based on these outstanding properties, [email protected] have great potential to be applied as the active tumor targeting contrast agent for MRI.Keywords
Funding Information
- Education Department of Sichuan Province (15ZB0209)
- National Natural Science Foundation of China (51372157)
- Sichuan Science and Technology Program (2017JY0255)
- Zigong City (2016XC11)
This publication has 45 references indexed in Scilit:
- Precise Study on Size-Dependent Properties of Magnetic Iron Oxide Nanoparticles for In Vivo Magnetic Resonance ImagingJournal of Nanomaterials, 2018
- Porous MnFe2O4-decorated PB nanocomposites: a new theranostic agent for boosted T1/T2 MRI-guided synergistic photothermal/magnetic hyperthermiaRSC Advances, 2018
- MRI based on iron oxide nanoparticles contrast agents: effect of oxidation state and architectureJournal of Nanoparticle Research, 2017
- In vivo T2* weighted MRI visualizes cardiac lesions in murine models of acute and chronic viral myocarditisPLOS ONE, 2017
- Development of New Contrast Agents for Imaging Function and Metabolism by Magnetic Resonance ImagingMagnetic Resonance Insights, 2017
- A superparamagnetic polymersome with extremely high T2 relaxivity for MRI and cancer-targeted drug deliveryBiomaterials, 2017
- Aptamer-PEG-modified Fe3O4@Mn as a novel T1- and T2- dual-model MRI contrast agent targeting hypoxia-induced cancer stem cellsScientific Reports, 2016
- Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agentsNanoscale, 2015
- Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imagingJournal of Controlled Release, 2013
- Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: Synthesis, stability, cytotoxicity and MR imagingInternational Journal of Pharmaceutics, 2011